These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Microbial keratitis complicated by acute hydrops following corneal collagen cross-linking for keratoconus. Ting DSJ; Bandyopadhyay J; Patel T Clin Exp Optom; 2019 Jul; 102(4):434-436. PubMed ID: 30520129 [No Abstract] [Full Text] [Related]
66. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776 [TBL] [Abstract][Full Text] [Related]
67. Achromobacter keratopathy. Del Valle M; Font RL Ophthalmology; 2009 Jan; 116(1):165-165.e2. PubMed ID: 19118705 [No Abstract] [Full Text] [Related]
68. The case against the use of steroids in the treatment of bacterial keratitis. Cohen EJ Arch Ophthalmol; 2009 Jan; 127(1):103-4. PubMed ID: 19139349 [No Abstract] [Full Text] [Related]
69. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. Jensen H; Zerouala C; Carrier M; Short B J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826 [TBL] [Abstract][Full Text] [Related]
70. The steroid controversy in bacterial keratitis. Acharya NR; Srinivasan M; Mascarenhas J; Ravindran M; Rajaraman R; Zegans M; McLeod S; Lietman TM Arch Ophthalmol; 2009 Sep; 127(9):1231. PubMed ID: 19752446 [No Abstract] [Full Text] [Related]
71. Problems with monotherapy for bacterial keratitis. Guzek JP Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6902-3; author reply 6903. PubMed ID: 21123792 [No Abstract] [Full Text] [Related]
72. From Sea to Bloodstream: Vibrio vulnificus Sepsis. Sheer AJ; Kline KP; Lo MC Am J Med; 2017 Oct; 130(10):1167-1169. PubMed ID: 28693913 [No Abstract] [Full Text] [Related]
75. [Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones]. Díaz Valle D; Alós Cortés JI; Arteaga Sánchez A; Toledano Fernández N; Poza Morales Y; Díaz-Valle T Arch Soc Esp Oftalmol; 2002 Jul; 77(7):397-9. PubMed ID: 12098814 [TBL] [Abstract][Full Text] [Related]
76. Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment. Ortega-Usobiaga J; Llovet-Osuna F; Djodeyre MR; Llovet-Rausell A; Beltran J; Baviera J J Cataract Refract Surg; 2015 Jun; 41(6):1210-6. PubMed ID: 26096523 [TBL] [Abstract][Full Text] [Related]
77. Fluoroquinolones in the treatment of bacterial keratitis. Bower KS; Kowalski RP; Gordon YJ Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818 [TBL] [Abstract][Full Text] [Related]
78. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641 [TBL] [Abstract][Full Text] [Related]
79. Clinical Characteristics of Stenotrophomonas maltophilia Keratitis. Wu AL; Yeh LK; Ma DH; Chen PY; Lin HC; Sun CC; Tan HY; Chen HC; Chen SY; Hsiao CH Cornea; 2016 Jun; 35(6):795-800. PubMed ID: 27100655 [TBL] [Abstract][Full Text] [Related]
80. Rationale for adjunctive topical corticosteroids in bacterial keratitis. Hindman HB; Patel SB; Jun AS Arch Ophthalmol; 2009 Jan; 127(1):97-102. PubMed ID: 19139348 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]